Table 1.
The correlation of TRIM31 expression and clinicopathological characteristics of breast cancer patients.
Parameters | Cases | TRIM31 expression | P values | |
---|---|---|---|---|
Low | High | |||
90 | 41 | 49 | ||
Age(years) | 0.572 | |||
<60 | 70 | 33 | 37 | |
≥60 | 20 | 8 | 12 | |
ER status | 0.277 | |||
Negative | 34 | 13 | 21 | |
Positive | 56 | 28 | 28 | |
PR status | 0.372 | |||
Negative | 35 | 18 | 17 | |
Positive | 55 | 23 | 32 | |
HER2 status | 0.447 | |||
Negative | 65 | 28 | 37 | |
Positive | 25 | 13 | 12 | |
P53 | 0.942 | |||
Wide type | 47 | 22 | 25 | |
Mutant | 28 | 12 | 16 | |
Deletion | 15 | 7 | 8 | |
Ki-67 status | 0.003 | |||
Negative | 25 | 5 | 20 | |
Positive | 65 | 36 | 29 | |
CK5/6 status | 0.199 | |||
Negative | 69 | 34 | 35 | |
Positive | 21 | 7 | 14 | |
E-cad status | 0.314 | |||
Negative | 26 | 14 | 12 | |
Positive | 64 | 27 | 37 | |
P63 status | 0.497 | |||
Negative | 73 | 32 | 41 | |
Positive | 17 | 9 | 8 | |
Tumor size (cm) | 0.020 | |||
≤2 | 36 | 11 | 25 | |
>2 | 54 | 30 | 24 | |
TNM stage | 0.006 | |||
I | 21 | 5 | 16 | |
II | 50 | 22 | 28 | |
III–IV | 19 | 14 | 5 | |
Histological grade | <0.001 | |||
I–II | 38 | 8 | 30 | |
III | 52 | 33 | 19 | |
Lymph node invasion | 0.008 | |||
Negative | 51 | 17 | 34 | |
Positive | 39 | 24 | 15 |